Health Care Technology
Company Overview of IMS Health Holdings, Inc.
IMS Health Holdings, Inc. provides information and technology services to healthcare industry worldwide. Its principal products include national information offerings that provide performance metrics related to the sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity through multiple channels; sub-national information offerings, which offer information related to the measurement of sales at the regional, zip code, and individual prescriber level; and OneKey, a reference database that provides a view of health care practitioners. The company also provides technology solutions, a cloud-based applications and associated implementation services; MIDAS...
83 Wooster Heights Road
Danbury, CT 06810
Founded in 1954
Key Executives for IMS Health Holdings, Inc.
IMS Health Holdings, Inc. does not have any Key Executives recorded.
IMS Health Holdings, Inc. Key Developments
IMS Health Holdings, Inc. Files Form 15
Oct 13 16
IMS Health Holdings, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock under the Securities Exchange Act of 1934, as amended. The par value of the company's common stock was $0.01 per share.
IMS Health Holdings, Inc. Announces Board Changes
Oct 3 16
IMS Health Holdings, Inc. announced that in connection with the closing of the merger, Ari Bousbib, John G. Danhakl, James Fasano, Karen L.Katen, Sharad S. Mansukani, Ronald A. Rittenmeyer, Todd B. Sisitsky and Bryan M. Taylor resigned as directors of the company, effective at the effective time of the merger.
IMS Health Holdings Intends To File Form 15
Oct 3 16
On October 3, 2016, IMS Health Holdings, Inc. (IMS Health) completed its previously announced merger with Quintiles Transnational Holdings Inc. (Quintiles), pursuant to the terms of the Agreement and Plan of Merger, dated as of May 3, 2016 (Merger Agreement), by and between Quintiles and IMS Health. The merger was accomplished by a “merger of equals” business combination of IMS Health with and into Quintiles (Merger), with Quintiles surviving the Merger (Surviving Corporation). Pursuant to the Merger Agreement, at the effective time of the Merger (Effective Time), each issued and outstanding share of IMS Health common stock was converted into the right to receive 0.3840 of a share of Surviving Corporation common stock, subject to the terms of the Merger Agreement. The Surviving Corporation will operate under the name Quintiles IMS Holdings, Inc., and its stock, including shares to be issued in the Merger, will trade on the New York Stock Exchange (Exchange). On October 3, 2016, IMS Health filed a notification of removal from listing on the Exchange on Form 25 to suspend the trading of shares of IMS Health common stock at the Effective Time. In addition, IMS Health intends to file with the SEC a certification and notice of termination on Form 15 requesting that all outstanding shares of IMS Health common stock be deregistered under Section 12(g) of the Securities Exchange Act of 1934, as amended (Exchange Act), and that IMS Health’s reporting obligations under Sections 13 and 15(d) of the Exchange Act with respect to its common units be suspended.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 3, 2016